Indefinite Delivery Contract W81K0225DA003

Award Date 2/1/25
Last Date to Order 9/30/29
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, a for-profit medical equipment manufacturer and supplier. The $3,438,000 single-award contract, awarded on November 1, 2020, aims to provide COVID-19 anti SARS-CoV-2 test reagents to the Brian D. Allgood Army Community Hospital in South Korea through September 30, 2023. An initial $10,000 firm fixed price delivery order was placed on...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The IDC, valued at $2,282,162.15, is for the procurement of immunoassay testing and related services over a period ending on March 30, 2029. The contract was not set aside for any particular business category. It is a single-award IDC to provide waterless integrated chemistry and immunoassay analyzers, reagents,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Chenkwang Science, a for-profit South Korean organization. The $232,645.53 single-award IDC tasks Chenkwang Science with supplying Biomerieux reagents and related microbiology testing services to support biological defense analytical capabilities at U.S. military medical facilities in South Korea, such as Brian Allgood Army Community Hospital and the U.S. Naval Hospital in Okinawa, Japan....
This federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $2,937,284.04, awarded by the Defense Health Agency (DHA) to the prime contractor BMI, a for-profit organization specializing in medical laboratory equipment and supplies. The IDC, awarded on July 1, 2020, is focused on providing reagents for the IRICell3000 system to support medical operations in South Korea through September 30, 2024. Under this IDC, the DHA and Army Medical Command have issued...
The Department of the Army Medical Command awarded a single-award indefinite delivery contract to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch to provide reagents, diagnostics chemistry/immunology analyzers, and associated equipment and services to support U.S. military medical operations at Camp Humphreys in South Korea. This contract facilitates the recurring issuance of firm fixed price delivery orders for the period of June 2019 through September 2023, with a total potential...
The Defense Health Agency (DHA) awarded a single-award indefinite delivery contract (IDC) to Synyoung Biomedics, a for-profit South Korean company, to provide radiometer blood gas analyzers, reagents, and related diagnostic equipment to support military medical facilities in South Korea. The IDC has a ceiling value of $421,130 and a period of performance through September 2027. Under this IDC, the DHA has issued three firm fixed-price delivery orders to Synyoung Biomedics, valued at $66,316,...
This federal contract IDV, awarded by the Defense agency's Medical Supply Chain division, is a single-award Indefinite Delivery Contract (IDC) with Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The contract has a ceiling value of $49,500,000 and a period of performance through December 9, 2025. The contract primarily supports the delivery of critical medical diagnostic equipment, reagents, and associated supplies to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated medical products and services. The $7.4 million single-award IDC covers a 5-year ordering period from October 1, 2023 to June 30, 2028 for "CHEMISTRY REAGENTS" to support the agency's medical laboratory testing requirements....
This federal contract IDV award, with the ID W81K0219D0004, is a single-award indefinite delivery contract held by the prime contractor BMI, a for-profit organization based in South Korea. The contract, valued at up to $1,282,010.00, was awarded on June 1, 2019 by the U.S. Army Medical Command, a component of the Defense Health Agency. The purpose of this contract is to provide Beckman Coulter reagents, medical equipment, and related supplies to support laboratory operations and patient care...
The key products and services being delivered under this federal Indefinite Delivery Contract (IDC) awarded to Namu Med, a for-profit company based in South Korea, are reagents for biochemical antibiotics susceptibility testing. The IDC, valued at $1,073,259.72, was awarded by the Defense Health Agency (DHA) and runs through September 30, 2027. It allows the DHA to issue task orders for these specialized testing materials on an as-needed basis to support military medical facilities in South...
  • W81K0225DA003
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, a for-profit medical equipment manufacturer and supplier. The $1,254,732 IDC is for the provision of VITROS XT7600 reagents to support medical operations at U.S. military facilities in South Korea over a period from February 1, 2025 to September 30, 2029.

This IDC is part of a broader portfolio of federal contracts held by Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, including a $900,000 Blanket Purchase Agreement with the Department of the Air Force Pacific Air Forces for VITROS 500 reagents, and a $3,438,000 Indefinite Delivery Contract with the Department of the Army Medical Command for COVID-19 testing supplies and reagents. These contract vehicles enable the company to provide ongoing diagnostic support to U.S. military medical facilities in the Asia-Pacific region, ensuring a consistent supply of essential medical equipment and reagents to support military healthcare operations.

Generated 7/31/25, 9:57 AM